Contrasting insulin sensitivity of endogenous glucose production rate in subjects with hepatocyte nuclear factor-1β and -1α mutations

Diabetes

Volumn 55, Issue 2, 2006, Pages 405-411

  Brackenridge, Anna ^a   Pearson, Ewan R ^b   Shojaee Moradie, Fariba ^c   Hattersley, Andrew T ^b   Russell Jones, David ^a   Umpleby, A Margot ^c,d  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^b PENINSULA MEDICAL SCHOOL   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE 6 PHOSPHATASE; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 1BETA; INSULIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GENE CONTROL; GENE FUNCTION; GENE MUTATION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORT; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY; LIPOLYSIS; LIVER; MALE; MEASUREMENT; PRIORITY JOURNAL;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCAGON; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MUTATION;

EID: 33644776570     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/diabetes.55.02.06.db05-1019     Document Type: Article

References (45)

1. Frayling TM, Bulamn MP, Ellard S, Appleton M, Dronsfield MJ, Mackie AD, Baird JD, Kaisaki PJ, Yamagata K, Bell GI, Bain SC, Hattersley AT: Mutations in the hepatocyte nuclear factor-1alpha gene are a common cause of maturity-onset diabetes of the young in the U.K. Diabetes 46:720-725, 1997
2. Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cockburn BN, Lindner T, Yamagata K, Ogata M, Tomonaga O, Kuroki H, Kasahara T, Iwamoto Y, Bell GI: Mutation in hepatocyte nuclear factor-1b gene (TCF2) associated with MODY. Nat Genet 17:384-385, 1997
3. Rey-Campos J, Chouard T, Yaniv M, Cereghini S: vHNF1 is a homeoprotein that activates transcription and forms heterodimers with HNF1. EMBO J 10:1445-1457, 1991
4. Lindner TH, Njølstad PR, Horikawa Y, Bostad L, Bell GI, Søvik O: A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1beta. Hum Mol Genet 8:2001-2008, 1999
5. Bingham C, Ellard S, Allen L, Bulman M, Shepherd M, Frayling T, Berry PJ, Clark PM, Lindner T, Bell GI, Ryffel GU, Nicholls AJ, Hattersley AT: Abnormal nephron development associated with a frameshift mutation in the transcription factor hepatocyte nuclear factor-1 beta. Kidney Int 57:898-907, 2000
6. Bingham C, Ellard S, Cole TR, Jones KE, Allen LI, Goodship JA, Goodship TH, Bakalinova-Pugh D, Russell GI, Woolf AS, Nicholls AJ, Hattersley AT: Solitary functioning kidney and diverse genital tract malformations associated with hepatocyte nuclear factor-1 beta mutations. Kidney Int 61:1243-1251, 2002
7. Furuta H, Furuta M, Sanke T, Ekawa K, Hanabusa T, Nishi M, Sasaki H, Nanjo K: Nonsense and missense mutations in the human hepatocyte nuclear factor-1 beta gene (TCF2) and their relation to type diabetes in Japanese. J Clin Endocrinol Metab 87:3859-3863, 2002
8. Bellanne-Chantelot C, Chauveau D, Gautier JF, Dubois-Laforgue D, Clauin S, Beaufils S, Wilhelm JF, Boitard C, Noel LH, Velho G, Timsit J: Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations. Ann Intern Med 140:510-517, 2004
9. Bingham C, Bulman M, Ellard S, Allen L, Lipkin G, van't Hoff W, Woolf A, Rizzoni G, Novelli G, Nicholls A, Hattersley A: Mutations in the HNF1-beta gene are associated with familial hypoplastic glomerulocystic kidney disease. Am J Hum Genet 68:219-224, 2001
10. Iwasaki N, Ogata M, Tomonaga O, Kuroki H, Kasahara T, Yano N, Iwamoto Y: Liver and kidney function in Japanese patients with maturity-onset diabetes of the young. Diabetes Care 21:2144-2148, 1998
11. Iwasaki N, Okabe I, Momoi MY, Ohashi H, Ogata M, Iwamoto Y: Splice site mutation in the hepatocyte factor-1 beta gene, IVSnt + 1G < A, associated with maturity-onset diabetes of the young, renal dysplasia and bicornuate uterus. Diabetologia 44:387-388, 2001
12. Byrne MM, Sturis J, Menzel S, Yamagata K, Fajans SS, Dronsfield MJ, Bain SC, Hattersley AT, Velho G, Froguel P, Bell GI, Polonsky KS: Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. Diabetes 45:1503-1510, 1996
13. Byrne MM, Sturis J, Fajans SS, Ortiz FJ, Stoltz A, Stoffel M, Smith MJ, Bell GI, Halter JB, Polonsky KS: Altered insulin secretory responses to glucose in subjects with a mutation on the MODY1 gene on chromosome 20. Diabetes 44:699-704, 1995
14. Pearson ER, Badman MK, Lockwood CR, Clark PM, Ellard S, Bingham C, Hattersley AT: Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1alpha and -1beta mutations. Diabetes Care 27:1102-1107, 2004
15. Lehto M, Tuomi T, Mahtani MM, Widen E, Forsblom C, Sarelin L, Gullstrom M, Isomaa B, Lehtovirta M, Hyrkko A, Kanninen T, Orho M, Manley S, Turner RC, Brettin T, Kirby A, Thomas J, Duyk G, Lander E, Taskinen MR, Groop L: Characterization of the MODY3 phenotype: early onset diabetes caused by an insulin secretion defect. J Clin Invest 99:582-591, 1997
16. Tripathy D, Carlsson AL, Lehto M, Isomaa B, Tuomi T, Groop L: Insulin secretion and insulin sensitivity in diabetic subgroups studies in the prediabetic and diabetic state. Diabetologia 43:1476-1483, 2000
17. DeFronzo RA, Simonson D, Ferrannini E: Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin dependent) and type 1 (insulin dependent) diabetes mellitus. Diabetologia 23:313-319, 1982
18. Bingham C, Ellard S, Van't Hoff WG, Simmonds HA, Marinaki AM, Badman MK, Winocour PH, Stride A, Lockwood CR, Nicholls AJ, Owen KR, Spyer G, Pearson ER, Hattersley AT: Atypical familial juvenile hyperuricemic nephropathy associated with a hepatocyte nuclear factor-1 beta gene mutation. Kidney Int 63:1645-1651, 2003
19. Shojaee-Moradie F, Jackson NC, Jones RH, Mallet AI, Hovorka R, Umpleby AM: Quantitative measurement of 3-O-methyl-D-glucose by gas chromatography-mass spectrometry as a measure of glucose transport in vivo. J Mass Spectrum 31:961-966, 1996
20. Sonksen P: Double Antibody Technique for the Simultaneous Assay of Insulin and Growth Hormone. Antoniades H, Ed. Cambridge, MA, Harvard University Press, 1976, p. 176-199
21. Steele R, Bishop JS, Dunn A, Altszuler N, Ratheb I, Debodo RC: Inhibition by insulin of hepatic glucose production in the normal dog. Am J Physiol 208:301-306, 1965
22. Finegood DT, Bergman RN, Vranic M: Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps: comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36:914-924, 1987
23. Finegood DT, Bergman RN: Optimal segments: a method for smoothing tracer data to calculate metabolic fluxes. Am J Physiol 244:E472-E479, 1983
24. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
25. Ekberg K, Landau BR, Wajngot A, Chandramouli V, Efendic S, Brunengraber H, Wahren J: Contributions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting. Diabetes 48:292-298, 1999
26. Stumvoll M, Meyer C, Mitrakou A, Nadkarni V, Gerich JE: Renal glucose production and utilization: new aspects in humans. Diabetologia 40:749-757, 1997
27. Vaxillaire M, Pueyo ME, Clement K, Fiet J, Timsit J, Philippe J, Robert J-J, Tappy L, Froguel P, Velho G: Insulin secretion and insulin sensitivity in diabetic and non-diabetic subjects with hepatic nuclear factor-1a (maturity-onset diabetes of the young-3) mutations. Eur J Endocrinol 141:609-618, 1999
28. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI: Impaired mitochondrial activity in the insulin resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664-671, 2004
29. Surmely JF, Guenat E, Philippe J, Dussoix P, Schneiter P, Temler E, Vaxillaire M, Froguel P, Jequier E, Tappy L: Glucose utilization and production in patients with maturity-onset diabetes of the young caused by a mutation of the hepatocyte nuclear factor-1alpha gene. Diabetes 47:1459-1463, 1998
30. DeFronzo RA: Lilly Lecture 1987: The triumvirate: beta-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 37:667-687, 1988
31. Berrish TS, Hetherington CS, Alberti KG, Wlaker M: Peripheral and hepatic insulin sensitivity in subjects with impaired glucose tolerance. Diabetologia 38:699-704, 1995
32. Hother-Nielsen O, Schmitz O, Bak J, Beck-Nielsen H: Enhanced hepatic insulin sensitivity but peripheral insulin resistance in patients with type 1 (insulin dependent) diabetes. Diabetologia 30:834-840, 1987
33. Yki-Jarvinen H, Taskinen M-R, Kiviluoto T, Hilden H, Helve E, Koivisto VA, Nikkila EA: Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro. J Clin Endocrinol Metab 59:1183-1192, 1984
34. Rubenfeld S, Garber AJ: Abnormal carbohydrate metabolism in chronic renal failure: the potential role of accelerated glucose production, increased gluconeogenesis and impaired glucose disposal. J Clin Invest 62:20-28, 1978
35. Yki-Jarvinen H, Koivisto VA: Natural course of insulin resistance in type 1 diabetes. N Engl J Med 315:224-230, 1986
36. Granner DK, O'Brien RM: Molecular physiology and genetics of NIDDM: importance of metabolic staging. Diabetes Care 15:369-395, 1992
37. Haber BA, Chin S, Chuang E, Buikhuisen W, Naji A, Taub R: High levels of glucose-6-phosphatase gene and protein expression reflect an adaptive response in proliferating liver and diabetes. J Clin Invest 95:832-841, 1995
38. Mithieux G, Vidal H, Zitoun C, Bruni N, Daniele N, Minassian C: Glucose-6-phosphatase mRNA and activity are increased to the same extent in kidney and liver of diabetic rats. Diabetes 45:891-896, 1996
39. Trinh KY, O'Doherty RM, Anderson P, Lange AJ, Newgard CB: Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats. J Biol Chem 273:31615-31620, 1998
40. O'Brien RM, Granner DK: Regulation of gene expression by insulin. Physiol Rev 76:1109 -1161, 1996
41. Hanson RW, Reshef L: Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu Rev Biochem 66:581-611, 1997
42. O'Brien RM, Streeper RS, Ayala JE, Stadelmaier BT, Hornbuckle LA: Insulin regulated gene expression. Biochem Soc Trans 29:552-558, 2001
43. Nakae J, Kitamura T, Silver DL, Accili D: The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J Clin Invest 108:1359-1367, 2001
44. Streeper RS, Eaton EM, Ebert DH, Chapman SC, Svitek CA, O'Brien RM: Hepatocyte nuclear factor-1 acts as an accessory factor to enhance the inhibitory action of insulin on mouse glucose-6-phosphatase gene transcription. Proc Natl Acad Sci U S A 95:9208-9213, 1998
45. Streeper RS, Svitek CA, Goldman JK, O'Brien RM: Differential role of HNF-1 in the regulation of glucose-6-phosphatase catalytic subunit gene transcription by cAMP in liver and kidney derived cell lines. J Biol Chem 275:12108 -12118, 2000